The JAK-STAT signaling pathway is involved in immune regulation, lymphocyte growth and differentiation, and promotes oxidative stress, serving as an attractive therapeutic target for COVID-19 treatment (Luo et al. 2020). The gene discussed is SOAT1; the disease is COVID-19.